Northwestern Mutual Wealth Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.17K | Buy |
+146
| New | +$3.17K | ﹤0.01% | 3141 |
|
|
2024
Q4 | – | Sell |
-133
| Closed | -$2.64K | – | 3660 |
|
|
2024
Q3 | $2.64K | Buy |
+133
| New | +$2.64K | ﹤0.01% | 3066 |
|
|
2024
Q2 | – | Sell |
-3
| Closed | -$48 | – | 3545 |
|
|
2024
Q1 | $48 | Sell |
3
-193
| -98% | -$3.09K | ﹤0.01% | 3475 |
|
|
2023
Q4 | $3.3K | Buy |
+196
| New | +$3.3K | ﹤0.01% | 2974 |
|
|
2023
Q1 | – | Sell |
-252
| Closed | -$4.69K | – | 3397 |
|
|
2022
Q4 | $4.69K | Buy |
252
+250
| +12,500% | +$4.65K | ﹤0.01% | 2741 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 3163 |
|
|
2022
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 3218 |
|
|
2022
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 3148 |
|
|
2021
Q4 | – | Sell |
-1
| Closed | – | – | 3164 |
|
|
2021
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3040 |
|
|
2018
Q2 | – | Sell |
-636
| Closed | -$2K | – | 2379 |
|
|
2018
Q1 | $2K | Buy |
+636
| New | +$2K | ﹤0.01% | 2029 |
|
|
2017
Q4 | – | Sell |
-500
| Closed | -$1K | – | 2317 |
|
|
2017
Q3 | $1K | Buy |
+500
| New | +$1K | ﹤0.01% | 2046 |
|